Opinion|Videos|January 19, 2026

Addressing Access Barriers and Formulary Restrictions

Panelists discuss how addressing payer restrictions and leveraging data-driven advocacy are essential for timely access to care.

Panelists discuss how payer-imposed step edits and prior authorizations continue to delay patient access to needed treatments. These administrative barriers often exacerbate symptom relapse and caregiver strain.

Panelists discuss how providers rely on real-world evidence and outcomes data to justify coverage approvals and ensure continuity of care.

Panelists discuss how policy reform and closer collaboration between clinicians, payers, and advocacy groups can streamline access and reduce inequities.

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.


Latest CME

Brand Logo

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences®

All rights reserved.

Secondary Brand Logo